Wockhardt ’s biological business was established in 2004, and since then the company has been focusing on the development and manufacture of biological products. Wockhardt is a fully integrated, innovation-led company committed to provide high quality biological products at an affordable price for needy patients and healthcare systems across the globe. Wockhardt holds 45 patents in biosimilar and biobetter development phase. Diabetic segment is one of the prime focus area and the product ... Wockhardt 's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) for the stock increased by 62% on a year-on-year basis to ₹178 crore, while margins expanded by over 900 basis points to 22.8% from 13.6% during the year-ago quarter. CHAIRMAN’S PROFILE Being different and making a difference. That sums up the vision, philosophy, conviction and driving force behind Dr. Habil F Khorakiwala who revels in venturing down the road less travelled. He founded Wockhardt in 1967. Today, the Wockhardt Group is India’s leading research-based, global healthcare enterprise with relevance in the fields of Pharmaceuticals, … Continue reading "Chairman’s Profile" THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY WOCKHARDT LIMITED (THE 'COMPANY') SOLELY TO COMPLY WITH THE SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED ('SEBI ICDR REGULATIONS') AND THE COMPANIES ACT, 2013 AND THE RULES MADE THEREUNDER, EACH AS AMENDED ('COMPANIES ACT').
